MedTrace Logo

Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders

NCT03723694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 259

Last updated 2024-08-27

No results posted yet for this study

Summary

The purpose of this study is to test the effect of a cocoa-derived dietary flavanol on brain structures and cognitive outcomes in a 12-week randomized controlled trial of 146 healthy participants, age 50-69, who will receive this cocoa derivative or a placebo. Th investigators will also examine the role of inflammation in this relationship.

Conditions

Interventions

DIETARY_SUPPLEMENT

650 mg of Cocoapro flavanols

12-week period during which participant will be asked to consume two cocoa-flavanol-containing capsules(650mg) twice a day with meals.

DIETARY_SUPPLEMENT

0 mg of Cocoapro flavanols

12-week period during which participant will be asked to consume two cocoa-flavanol-containing capsules(0mg) twice a day with meals.

Sponsors & Collaborators

Principal Investigators

  • Richard P. Sloan, PhD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-03-05
Completion
2023-06-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03723694 on ClinicalTrials.gov